Key facts
- This page summarizes Joseph K. Schachle's Form 4 filing for Opus Genetics, Inc. (IRD).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 27 Jul 2026, 16:07.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Additional SEC filing notes
Footnote F1
The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person.